Neumora Therapeutics (NMRA) Times Interest Earned (2025 - 2026)

Neumora Therapeutics' Times Interest Earned history runs 5 years deep, the most recent figure standing at -$28.51 for Q1 2026.

• In Q1 2026, Times Interest Earned changed N/A year-over-year to -$28.51; the TTM figure through Mar 2026 stood at -$57.35 (changed N/A YoY), while the FY2025 annual figure was -$0.73, up 26.71% from the prior year.
• Times Interest Earned for Q1 2026 stood at -$28.51, up from -$28.72 in the prior quarter.
• The five-year high for Times Interest Earned was -$0.22 in Q4 2022, with the low at -$57.7 in Q3 2025.
• The 5-year median for Times Interest Earned is -$1.26 (2024), against an average of -$16.85.
• The sharpest annual moves came in 2024 and 2025: Times Interest Earned sank 110.35% in 2024, then plunged 5392.29% in 2025.
• Neumora Therapeutics' Times Interest Earned stood at -$0.22 in 2022, then plunged by 166.3% to -$0.58 in 2023, then slumped by 81.8% to -$1.05 in 2024, then slumped by 2634.05% to -$28.72 in 2025, then increased by 0.73% to -$28.51 in 2026.
• Business Quant data shows NMRA's Times Interest Earned at -$28.51 in Q1 2026, -$28.72 in Q4 2025, and -$57.7 in Q3 2025.